Acute Depletion Redefines the Division of Labor among DNA Methyltransferases in Methylating the Human Genome

Cell Reports

Volumn 9, Issue 4, 2014, Pages 1554-1566

  Tiedemann, Rochelle L ^a,c   Putiri, Emily L ^a   Lee, Jeong Heon ^a,b   Hlady, Ryan A ^a   Kashiwagi, Katsunobu ^a   Ordog, Tamas ^a,b   Zhang, Zhiguo ^a,b   Liu, Chen ^d   Choi, Jeong Hyeon ^c   Robertson, Keith D ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; DNA METHYLTRANSFERASE 3L; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; 5 METHYLCYTOSINE; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; DNMT3L PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; CPG ISLAND; CREBBP GENE; DNA METHYLATION; DOWN REGULATION; ENZYME ACTIVITY; GENE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PTPRN2 GENE; RNA SPLICING; RNA TRANSLATION; TACSTD2 GENE; UBIQUITINATION; UPREGULATION; DEFICIENCY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE LOCUS; GENETIC EPIGENESIS; GENETICS; HUMAN; HUMAN GENOME; METABOLISM; TUMOR CELL LINE;

5-METHYLCYTOSINE; CELL LINE, TUMOR; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; GENETIC LOCI; GENOME, HUMAN; HUMANS; RNA, SMALL INTERFERING;

EID: 84964698666     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.10.013     Document Type: Article

References (34)

1. Bachman K.E., Park B.H., Rhee I., Rajagopalan H., Herman J.G., Baylin S.B., Kinzler K.W., Vogelstein B. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 2003, 3:89-95.
2. Bourc'his D., Xu G.-L., Lin C.-S., Bollman B., Bestor T.H. Dnmt3L and the establishment of maternal genomic imprints. Science 2001, 294:2536-2539.
3. Challen G.A., Sun D., Jeong M., Luo M., Jelinek J., Berg J.S., Bock C., Vasanthakumar A., Gu H., Xi Y., et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat. Genet. 2012, 44:23-31.
4. Chen C.-C., Wang K.-Y., Shen C.-K.J. The mammalian de novo DNA methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcytosine dehydroxymethylases. J.Biol. Chem. 2012, 287:33116-33121.
5. Egger G., Jeong S., Escobar S.G., Cortez C.C., Li T.W.H., Saito Y., Yoo C.B., Jones P.A., Liang G. Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival. Proc. Natl. Acad. Sci. USA 2006, 103:14080-14085.
6. Frauer C., Hoffmann T., Bultmann S., Casa V., Cardoso M.C., Antes I., Leonhardt H. Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA domain. PLoS ONE 2011, 6:e21306.
7. Hansen R.S., Wijmenga C., Luo P., Stanek A.M., Canfield T.K., Weemaes C.M.R., Gartler S.M. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA 1999, 96:14412-14417.
8. Hashimoto H., Liu Y., Upadhyay A.K., Chang Y., Howerton S.B., Vertino P.M., Zhang X., Cheng X. Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res. 2012, 40:4841-4849.
9. Huang Y., Chavez L., Chang X., Wang X., Pastor W.A., Kang J., Zepeda-Martínez J.A., Pape U.J., Jacobsen S.E., Peters B., Rao A. Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 2014, 111:1361-1366.
10. Jin B., Ernst J., Tiedemann R.L., Xu H., Sureshchandra S., Kellis M., Dalton S., Liu C., Choi J.-H., Robertson K.D. Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells. Cell Reports 2012, 2:1411-1424.
11. Kim G.-D., Ni J., Kelesoglu N., Roberts R.J., Pradhan S. Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 2002, 21:4183-4195.
12. Kolasinska-Zwierz P., Down T., Latorre I., Liu T., Liu X.S., Ahringer J. Differential chromatin marking of introns and expressed exons by H3K36me3. Nat. Genet. 2009, 41:376-381.
13. Laurent L., Wong E., Li G., Huynh T., Tsirigos A., Ong C.T., Low H.M., Kin Sung K.W., Rigoutsos I., Loring J., Wei C.-L. Dynamic changes in the human methylome during differentiation. Genome Res. 2010, 20:320-331.
14. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69:915-926.
15. Linhart H.G., Lin H., Yamada Y., Moran E., Steine E.J., Gokhale S., Lo G., Cantu E., Ehrich M., He T., et al. Dnmt3b promotes tumorigenesis invivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev. 2007, 21:3110-3122.
16. Lister R., Pelizzola M., Dowen R.H., Hawkins R.D., Hon G., Tonti-Filippini J., Nery J.R., Lee L., Ye Z., Ngo Q.-M., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
17. Lister R., Mukamel E.A., Nery J.R., Urich M., Puddifoot C.A., Johnson N.D., Lucero J., Huang Y., Dwork A.J., Schultz M.D., et al. Global epigenomic reconfiguration during mammalian brain development. Science 2013, 341:1237905.
18. Malik P., Cashen A.F. Decitabine in the treatment of acute myeloid leukemia in elderly patients. Cancer Manag. Res. 2014, 6:53-61.
19. Maunakea A.K., Nagarajan R.P., Bilenky M., Ballinger T.J., D'Souza C., Fouse S.D., Johnson B.E., Hong C., Nielsen C., Zhao Y., et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010, 466:253-257.
20. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
21. Ostler K.R., Yang Q., Looney T.J., Zhang L., Vasanthakumar A., Tian Y., Kocherginsky M., Raimondi S.L., DeMaio J.G., Salwen H.R., et al. Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma. Cancer Res. 2012, 72:4714-4723.
22. Palii S.S., Van Emburgh B.O., Sankpal U.T., Brown K.D., Robertson K.D. DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol. Cell. Biol. 2008, 28:752-771.
23. Putiri E.L., Tiedemann R.L., Liu C., Choi J.-H., Robertson K.D. Impact of human MLL/COMPASS and polycomb complexes on the DNA methylome. Oncotarget 2014, 5:6338-6352.
24. Ramsahoye B.H., Biniszkiewicz D., Lyko F., Clark V., Bird A.P., Jaenisch R. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl. Acad. Sci. USA 2000, 97:5237-5242.
25. Rhee I., Bachman K.E., Park B.H., Jair K.-W., Yen R.-W.C., Schuebel K.E., Cui H., Feinberg A.P., Lengauer C., Kinzler K.W., et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002, 416:552-556.
26. Shah M.Y., Vasanthakumar A., Barnes N.Y., Figueroa M.E., Kamp A., Hendrick C., Ostler K.R., Davis E.M., Lin S., Anastasi J., et al. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Cancer Res. 2010, 70:5840-5850.
27. Sharif J., Muto M., Takebayashi S., Suetake I., Iwamatsu A., Endo T.A., Shinga J., Mizutani-Koseki Y., Toyoda T., Okamura K., et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007, 450:908-912.
28. Shukla S., Kavak E., Gregory M., Imashimizu M., Shutinoski B., Kashlev M., Oberdoerffer P., Sandberg R., Oberdoerffer S. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 2011, 479:74-79.
29. Sperger J.M., Chen X., Draper J.S., Antosiewicz J.E., Chon C.H., Jones S.B., Brooks J.D., Andrews P.W., Brown P.O., Thomson J.A. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl. Acad. Sci. USA 2003, 100:13350-13355.
30. Stergachis A.B., Haugen E., Shafer A., Fu W., Vernot B., Reynolds A., Raubitschek A., Ziegler S., LeProust E.M., Akey J.M., Stamatoyannopoulos J.A. Exonic transcription factor binding directs codon choice and affects protein evolution. Science 2013, 342:1367-1372.
31. Sun L., Huang L., Nguyen P., Bisht K.S., Bar-Sela G., Ho A.S., Bradbury C.M., Yu W., Cui H., Lee S., et al. DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation. Cancer Res. 2008, 68:2726-2735.
32. Yamashita Y., Yuan J., Suetake I., Suzuki H., Ishikawa Y., Choi Y.L., Ueno T., Soda M., Hamada T., Haruta H., et al. Array-based genomic resequencing of human leukemia. Oncogene 2010, 29:3723-3731.
33. Yu M., Hon G.C., Szulwach K.E., Song C.-X., Jin P., Ren B., He C. Tet-assisted bisulfite sequencing of 5-hydroxymethylcytosine. Nat. Protoc. 2012, 7:2159-2170.
34. Ziller M.J., Müller F., Liao J., Zhang Y., Gu H., Bock C., Boyle P., Epstein C.B., Bernstein B.E., Lengauer T., et al. Genomic distribution and inter-sample variation of non-CpG methylation across human cell types. PLoS Genet. 2011, 7:e1002389.